September 16, 2014 10:24 AM ET

Pharmaceuticals

Company Overview of Medinox, Inc.

Company Overview

Medinox, Inc. operates as a pharmaceutical company. It develops small molecule drugs to treat various unmet medical needs, including sepsis, arthritis and inflammation, diabetes, and sickle cell anemia. The company’s research and clinical development programs include nitric oxide neutralizers, such as NOX-100, an injectable compound for septic shock; and oral compounds for type-2 diabetes. It also develops Prodrug programs, such as non steroidal anti-inflammatory drugs for treating inflammation and pain; MX-1094, a naproxen; and MX-1520, a sickle cell anemia therapeutic. The company was founded in 1995 and is based in Carlsbad, California.

6120 Paseo Del Norte

Suite B-2

Carlsbad, CA 92009

United States

Founded in 1995

Phone:

760-603-8989

Fax:

760-603-8558

Key Executives for Medinox, Inc.

Senior Vice President of Clinical Development
Vice President of Corporate Development
Age: 58
Consultant
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
KeyBay Pharma, Inc. United States
OncoPep, Inc. United States
Riogin Corporation United States
AvMax, Inc. United States
Pedinol Pharmacal, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medinox, Inc., please visit www.medinox.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.